GSK3B and colorectal carcinoma: It was observed that, compared to the control group, AXIN1 protein level was significantly reduced in CRC tissues, while p‐GSK‐3β, β‐catenin, Wnt5a, CyclinD1 and c‐Myc levels were significantly increased (Figure 6A).